Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols

Diabetes

Volumn 46, Issue 7, 1997, Pages 1167-1171

  Saad, Mohammed F ^a,b   Steil, Garry M ^a   Kades, Wagdy W ^a   Ayad, Maged F ^a   Elsewafy, Wagih A ^a   Boyadjian, Rima ^a   Jinagouda, Sujata D ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN; TOLBUTAMIDE;

ADULT; ARTICLE; CLINICAL PROTOCOL; COMPUTER MODEL; COMPUTER PROGRAM; CONTINUOUS INFUSION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030912280     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.7.1167     Document Type: Article

References (34)

1. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
2. Donner CC, Fraze E, Chen Y-DI, Hollenbeck CB, Foley JE, Reaven GM: Presentation of a new method for specific measurement of in vivo insulin-stimulated glucose disposal in humans: comparison of this approach with the insulin clamp and minimal model techniques. J Clin Endocrinol Metab 60:723-726, 1985
3. Foley JE, Chen Y-DI, Lardinois CK, Hollenbeck CB, Liu GC, Reaven GM: Estimates of in vivo insulin action in humans: comparison of the insulin clamp and the minimal model techniques. Horm Metab Res 17:406-409, 1985
4. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
5. Beard JC, Bergman RN, Ward WK, Porte D Jr: The insulin sensitivity index in nondiabetic man: correlation between clamp-derived and IVGTT-derived values. Diabetes 35:362-369, 1986
6. Finegood DT, Hramiak IM, Dupre J: A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549, 1990
7. Welch S, Gebhart SS, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
8. Coates PA, Ollerton RL, Luzio SD, Ismail IS, Owens DR: Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM. Diabetes 42:1635-1641, 1993
9. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41:1540-1546, 1992
10. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-DI, Sands RE, Pei D, Savage PJ, Bergman RN for the Insulin Resistance Atherosclerosis Study: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
11. Valdes CT, Elkind-Hirsch KE: Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab 72:642-646, 1991
12. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
13. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
14. Herbert V, Lau K-S, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
15. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
16. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430, 1959
17. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
18. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98-105, 1986
19. Van Cauter EV, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
20. Schenk WG Jr, McDonald JC, McDonald K, Drapanas T: Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals. Ann Surg 156:463-471, 1962
21. GraphPad Prism Version 2.0, GraphPad Software, Inc., San Diego, CA, 1995
22. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
23. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HLA, Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90:1769-1777, 1992
24. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
25. Prigeon RL, Roder ME, Porte D Jr, Kahn SE: The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique: evidence for saturable insulin transport in humans. J Clin Invest 97:501-507, 1996
26. Freidenberg GR, Suter SL, Henry RR, Reichart D, Olefsky JM: In vivo stimulation of the insulin receptor kinase in human skeletal muscle: correlation with insulin-stimulated glucose disposal during euglycemic clamp studies. J Clin Invest 87:2222-2229, 1991
27. Daniels EL, Lewis SB: Acute tolbutamide administration alone or combined with insulin enhances glucose uptake in the perfused rat hindlimb. Endocrinology 110:1840-1842, 1982
28. Kramer JH, Lampson WG, Schaffer SW: Effect of tolbutamide on myocardial energy metabolism. Am J Physiol 245:H313-H319, 1983
29. Joost H-G, Arend W, Holze SA: Effects of tolbutamide on insulin binding to isolated fat cells of the rat. Biochem Pharmacol 31:1227-1231, 1982
30. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45:454-462, 1996
31. Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, Olefsky JM: The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 33:762-770, 1984
32. Davis SN, Butler PC, Brown M, Beer S, Sobey W, Hanning I, Home PD, Hales CN, Alberti KGMM: The effects of human proinsulin on glucose turnover and intermediary metabolism. Metabolism 40:953-961, 1991
33. Glauber HS, Revers RR, Henry R, Schmeiser L, Wallace P, Kolterman OG, Cohen RM, Rubenstein AH, Galloway JA, Frank BH, Olefsky JM: In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man. Diabetes 35:311-317, 1986
34. Cobelli C, Thomaseth K: The minimal model of glucose disappearance: optimal input studies. Math Biosci 83:25-30, 1987